# Phase I Pharmacokinetic Study of RX0041-2

> **NCT02667106** · PHASE1 · COMPLETED · sponsor: **Pharmaceutical Project Solutions, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Drug Reaction to Analgesic Nos

## Interventions

- **DRUG:** RX0041-2

## Key facts

- **NCT ID:** NCT02667106
- **Lead sponsor:** Pharmaceutical Project Solutions, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02667106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02667106, "Phase I Pharmacokinetic Study of RX0041-2". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02667106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*